Nrf2 inhibitors (Aquapharm)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNrf2 inhibitors (Aquapharm)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 inhibitors
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAquapharm Biodiscovery Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAquapharm Biodiscovery Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesCardiovascular DiseasesCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A